Document Detail

Aggressive pituitary adenomas-diagnosis and emerging treatments.
MedLine Citation:
PMID:  24821329     Owner:  NLM     Status:  Publisher    
The WHO categorizes pituitary tumours as typical adenomas, atypical adenomas and pituitary carcinomas, with typical adenomas constituting the major class. However, the WHO classification does not provide an accurate correlation between histopathological findings and clinical behaviour. Tumours lacking typical histological features are classified as atypical, but not all are clinically atypical or exhibit aggressive behaviour. Pituitary carcinomas, by definition, have craniospinal or systemic metastases, although not all display classical cytological features of malignancy. Aggressive pituitary adenomas, defined from a clinical perspective, have earlier and more frequent recurrences and can be resistant to conventional treatments. Specific biomarkers have not yet been identified that can distinguish between clinically aggressive and nonaggressive pituitary adenomas, although the antigen Ki-67 proliferation index might be of value. This Review highlights the need to develop new biomarkers to facilitate the early detection of clinically aggressive pituitary adenomas and discusses emerging markers that hold promise for their identification. Defining aggressiveness is of crucial importance for improving the management of patients by enhancing prognostic predictions and effectiveness of treatment. New drugs, such as temozolomide, have potential use in the management of these patients; anti-VEGF therapy, mTOR and tyrosine kinase inhibitors are also potentially useful in managing selected patients.
Antonio Di Ieva; Fabio Rotondo; Luis V Syro; Michael D Cusimano; Kalman Kovacs
Related Documents :
7259239 - Cutaneous eruptions in congenital tuberculosis.
23371299 - Multiple duplication cysts diagnosed prenatally: case report and review of the literature.
24779819 - Dementia: early diagnosis.
15006079 - Extramammary paget's disease masquerading as lichen sclerosus.
25021789 - Pth-096 the sensitivity of eus fna of solid pancreatic lesions, working from a regional...
24475839 - C-arm cone-beam ct-guided percutaneous transthoracic needle biopsy of lung nodules: cli...
19644539 - Glandular odontogenic cyst: report of two cases and review of literature.
16121049 - The capillary lobule: a deceptively benign feature of post-radiation angiosarcoma of th...
7256529 - Hemangioma calcificans--a benign epileptogenic lesion.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-5-13
Journal Detail:
Title:  Nature reviews. Endocrinology     Volume:  -     ISSN:  1759-5037     ISO Abbreviation:  Nat Rev Endocrinol     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-5-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101500078     Medline TA:  Nat Rev Endocrinol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Beyond intestinal soap-bile acids in metabolic control.
Next Document:  Lipid-like self-assembling peptide nanovesicles for drug delivery.